HAE

Haemonetics Corp

Apr 08 • 04:00PM ET

59.53

-0.03 -0.05 %

Healthcare • Medical Devices • USA • NYSE

Peers: ABT BDX BAX EW MDT HOLX STE BSX TFX XRAY

| Held by: VTI IJH VB IWM VBK VXF IWO MDY VTWO SPMD

Index	RUT	P/E	16.36	EPS (ttm)	3.64	Insider Own	1.43%	Shs Outstand	46.83M	Perf Week	5.62%
Market Cap	2.77B	Forward P/E	11.22	EPS next Y	5.31	Insider Trans	0.21%	Shs Float	45.81M	Perf Month	-7.32%
Enterprise Value	3.63B	PEG	1.26	EPS next Q	1.27	Inst Own	112.91%	Short Float	4.16%	Perf Quarter	-28.08%
Income	175.44M	P/S	2.10	EPS this Y	8.24%	Inst Trans	-5.53%	Short Ratio	2.16	Perf Half Y	20.14%
Sales	1.32B	P/B	3.06	EPS next Y	7.30%	ROA	6.99%	Short Interest	1.90M	Perf YTD	-25.73%
Book/sh	19.46	P/C	7.61	EPS next 5Y	8.91%	ROE	19.30%	52W High	87.32 -31.83%	Perf Year	6.23%
Cash/sh	7.82	P/FCF	8.98	EPS past 3/5Y	57.59% 17.48%	ROIC	9.58%	52W Low	47.31 25.82%	Perf 3Y	-27.69%
Dividend Est.	-	EV/EBITDA	10.19	Sales past 3/5Y	11.07% 6.60%	Gross Margin	55.92%	Volatility	3.50% 3.25%	Perf 5Y	-47.68%
Dividend TTM	-	EV/Sales	2.75	EPS Y/Y TTM	42.52%	Oper. Margin	18.47%	ATR (14)	1.96	Perf 10Y	74.78%
Dividend Ex-Date	-	Quick Ratio	1.15	Sales Y/Y TTM	-4.02%	Profit Margin	13.31%	RSI (14)	51.71	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.75	EPS Q/Q	28.61%	SMA20	2.70%	Beta	0.52	Target Price	86.50
Payout	0.00%	Debt/Eq	1.34	Sales Q/Q	-2.75%	SMA50	-2.04%	Rel Volume	1.02	Prev Close	59.56
Employees	3023	LT Debt/Eq	1.01	Earnings	Feb 05 BMO	SMA200	-8.18%	Avg Volume	883.60K	Price	59.53
IPO	May 10, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.83% 2.13%	Trades		Volume	904,031	Change	-0.05%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-15-25	Downgrade	Needham	Buy → Hold
Dec-11-25	Downgrade	Citigroup	Buy → Neutral	$88
Aug-11-25	Downgrade	Raymond James	Strong Buy → Outperform	$78
Aug-08-25	Reiterated	Barrington Research	Outperform	$95 → $86
Aug-08-25	Downgrade	JP Morgan	Overweight → Neutral	$62
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$90
Jun-26-25	Initiated	Robert W. Baird	Outperform	$87
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform	$95 → $68
Dec-06-24	Initiated	JP Morgan	Overweight	$116
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy	$120
Sep-13-24	Initiated	CL King	Buy	$116
Sep-11-24	Initiated	BofA Securities	Neutral	$85
Sep-10-24	Initiated	BTIG Research	Buy	$112
Jun-12-24	Upgrade	Needham	Hold → Buy	$112
Oct-13-22	Initiated	Mizuho	Buy	$90
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$75 → $59
Aug-17-21	Resumed	Raymond James	Outperform	$75
Jun-17-21	Initiated	Citigroup	Buy	$75
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform

Show Previous Ratings

Apr-01-26 04:05PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 (PR Newswire)
Mar-30-26 09:01PM	GVS SpA (STU:4YQ) Q4 2025 Earnings Call Highlights: Strong Safety Division Growth Amidst Challenges (GuruFocus.com)
04:15PM	Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP XL Venous Vascular Closure System (PR Newswire)
Mar-11-26 05:26AM	Haemonetics price target lowered to $70 from $75 at Citi (TipRanks)
Mar-05-26 10:35PM	A Look Back at Medical Devices & Supplies - Specialty Stocks' Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack (StockStory)
11:04PM	Loading…
Mar-03-26 11:04PM	3 Reasons HAE is Risky and 1 Stock to Buy Instead (StockStory)
Mar-02-26 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Feb-23-26 04:15PM	Haemonetics Receives FDA Clearance for NexSys PCS Plasma Collection System with Persona PLUS Technology (PR Newswire)
Feb-20-26 04:05PM	Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference (PR Newswire)
Feb-18-26 01:13AM	Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 (Insider Monkey)
Feb-16-26 09:16AM	Strong Competitive Position Drove Haemonetics Corporation's (HAE) Earnings Growth (Insider Monkey)
Feb-12-26 12:34AM	5 Revealing Analyst Questions From Haemonetics's Q4 Earnings Call (StockStory)
Feb-10-26 09:15AM	Haemonetics (HAE) International Revenue Performance Explored (Zacks)
Feb-09-26 05:03PM	Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp (GuruFocus.com)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
06:28PM	Loading…
Feb-06-26 06:28PM	Haemonetics Q3 Earnings Call Highlights (MarketBeat) -8.74%
09:45AM	Haemonetics (HAE) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:31AM	Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips (Zacks)
12:34AM	HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results (StockStory)
Feb-05-26 02:04PM	Haemonetics Corp (HAE) Q3 2026 Earnings Call Highlights: Strong Plasma Growth and Margin ... (GuruFocus.com)
09:30AM	Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Haemonetics (HAE) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:35AM	Haemonetics's (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars (StockStory)
06:23AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website (PR Newswire)
Feb-03-26 10:03PM	What To Expect From Haemonetics's (HAE) Q4 Earnings (StockStory)
Jan-30-26 02:31PM	Haemonetics (HAE) Sparks Confidence Following Vivasure Acquisition (Insider Monkey)
Jan-29-26 05:25PM	Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Jan-28-26 10:33PM	Reflecting On Medical Devices & Supplies - Specialty Stocks' Q3 Earnings: Haemonetics (NYSE:HAE) (StockStory)
Jan-22-26 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
09:42AM	Loading…
Jan-15-26 09:42AM	Is it Apt to Retain HAE Stock in Your Portfolio for Now? (Zacks)
Jan-13-26 07:44AM	Haemonetics price target raised to $93 from $90 at Barrington (TipRanks)
Jan-12-26 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
06:53AM	Haemonetics acquires Ireland-based Vivasure (Medical Device Network)
Jan-09-26 12:10PM	Will Haemonetics (HAE) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:41AM	Haemonetics to acquire Vivasure Medical (MedTech Dive)
08:16AM	Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition (Benzinga)
08:00AM	Vivasure Medical Announces Acquisition by Haemonetics Corporation (Business Wire)
06:15AM	Haemonetics Acquires Vivasure Medical Limited (PR Newswire)
Jan-08-26 11:33PM	1 Small-Cap Stock Worth Your Attention and 2 We Avoid (StockStory)
Jan-07-26 06:17PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 (PR Newswire)
Jan-06-26 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-02-26 06:00AM	Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-25-25 07:42AM	Do You Believe in the Long-Term Growth Potential of Haemonetics Corporation (HAE)? (Insider Monkey)
Dec-19-25 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Dec-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-16-25 12:26PM	Health Care Roundup: Market Talk (The Wall Street Journal)
08:15AM	Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3 (Insider Monkey)
Dec-15-25 12:46PM	Why Haemonetics (HAE) Shares Are Trading Lower Today (StockStory)
09:50AM	Here's Why Haemonetics (HAE) is a Strong Momentum Stock (Zacks)
Dec-12-25 07:11AM	Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? (Zacks)
Dec-11-25 11:41AM	Why Haemonetics (HAE) Stock Is Down Today (StockStory)
Dec-03-25 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
Nov-28-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-17-25 11:02PM	3 Reasons to Sell HAE and 1 Stock to Buy Instead (StockStory)
09:15AM	Interpreting Haemonetics (HAE) International Revenue Trends (Zacks)
Nov-14-25 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Nov-13-25 09:50AM	Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term (Zacks)
12:37AM	5 Insightful Analyst Questions From Haemonetics's Q3 Earnings Call (StockStory)
Nov-11-25 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Nov-07-25 12:47PM	Why Haemonetics Stock Was on Fire Thursday (Motley Fool)
09:45AM	HAE Q3 Deep Dive: Margin Expansion and Portfolio Rationalization Drive Outperformance (StockStory)
Nov-06-25 02:04PM	Haemonetics Corp (HAE) Q2 2026 Earnings Call Highlights: Strong Plasma Growth and Margin ... (GuruFocus.com) +32.31%
01:56PM	Why Are Haemonetics (HAE) Shares Soaring Today (StockStory)
11:09AM	Stock Market Today: U.S. Stocks Plummet After Fed Comments, Surprise Layoff Data, and Threat of U.S. Flight Cuts (TheStreet)
09:30AM	Haemonetics (HAE) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:57AM	Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8% (StockStory)
07:15AM	Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates (Zacks)
06:12AM	Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website (PR Newswire)
Nov-04-25 10:08PM	What To Expect From Haemonetics's (HAE) Q3 Earnings (StockStory)
08:05AM	Haemonetics Corporation (HAE) is Navigating Challenges Through Earnings Growth (Insider Monkey)
Nov-03-25 08:11AM	Should You Hold Haemonetics Corporation (HAE)? (Insider Monkey)
Oct-28-25 12:01AM	Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-20-25 11:31PM	Unpacking Q2 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks (StockStory)
Oct-19-25 11:34PM	Medical Devices & Supplies - Specialty Stocks Q2 Results: Benchmarking Haemonetics (NYSE:HAE) (StockStory)
Oct-09-25 04:05PM	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 (PR Newswire)
Sep-18-25 10:39AM	Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care (Insider Monkey)
Aug-23-25 04:00AM	Mizuho Reduces PT on Haemonetics Corporation (HAE) Following Fiscal Q1 2025 Results (Insider Monkey)
Aug-14-25 01:41AM	The Top 5 Analyst Questions From Haemonetics's Q2 Earnings Call (StockStory)
Aug-11-25 09:38AM	HAE Q2 Deep Dive: Margin Expansion Amid Revenue Decline and Product Execution Challenges (StockStory)
09:33AM	Arm initiated, Adobe downgraded: Wall Street's top analyst calls (The Fly)
09:15AM	Understanding Haemonetics (HAE) Reliance on International Revenue (Zacks)
Aug-07-25 02:08PM	Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24% (StockStory) -26.58%
09:30AM	Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
07:10AM	Haemonetics (HAE) Q1 Earnings and Revenues Surpass Estimates (Zacks)
06:07AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website (PR Newswire)
Aug-06-25 09:15AM	Unlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics (Zacks)
Aug-05-25 11:18PM	Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jul-31-25 10:00AM	Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-27-25 10:01AM	Haemonetics Builds Momentum with New Buy Rating and Growth Promise (Insider Monkey)
Jul-23-25 07:40AM	Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Jul-10-25 04:52PM	Integer Appoints Michael Coyle to Board of Directors (GlobeNewswire)
Jul-09-25 11:38PM	Unpacking Q1 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks (StockStory)
04:05PM	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 (PR Newswire)
10:28AM	Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes (Investing.com)
Jun-27-25 05:44AM	5 Must-Read Analyst Questions From Haemonetics's Q1 Earnings Call (StockStory)
Jun-05-25 07:56AM	HAE Q1 Earnings Call: Revenue Misses Expectations, Margin Expansion and Product Focus Highlighted (StockStory)
May-30-25 06:00AM	Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference (PR Newswire)

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KROLL MARK W	Director	Nov 10 '25	Buy	70.56	1,400	98,784	24,757	Nov 12 04:18 PM
Llorens Josep	Former Officer	Jun 26 '25	Proposed Sale	74.94	18,630	1,396,132		Jun 26 10:49 AM
Strong Stewart W	Former Officer	Jun 12 '25	Proposed Sale	71.46	708	50,593		Jun 12 04:51 PM
Strong Stewart W	Officer	Jun 04 '25	Proposed Sale	69.90	7,705	538,580		Jun 04 10:06 AM
Strong Stewart W	Officer	Jun 02 '25	Proposed Sale	67.47	2,835	191,277		Jun 02 01:16 PM
Llorens Josep	Officer	May 19 '25	Proposed Sale	69.37	1,547	107,319		May 19 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HAE

Haemonetics Corp

Upgrade your Finviz experience